# Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma

> **NCT02304289** · PHASE1 · TERMINATED · sponsor: **University Hospital, Ghent** · enrollment: 2 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Artesunate

## Key facts

- **NCT ID:** NCT02304289
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** slow recruitment of patients
- **Last updated:** 2021-10-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02304289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02304289, "Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02304289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*